Antithrombotic/Antiplatelet Treatment in Transcatheter Structural Cardiac Interventions—PFO/ASD/LAA Occluder and Interatrial Shunt Devices
Transcatheter interventions enable safe and efficient treatment of various structural heart diseases. However, therapy does not finished with the end of the procedure. Device thrombosis is a possible serious complication. Therefore, careful patient management should include optimal antiplatelet or a...
Main Authors: | Anna Olasinska-Wisniewska, Marek Grygier |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-06-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcvm.2019.00075/full |
Similar Items
-
"Interventional Closure of Patent Foramen Ovale (PFO) with Amplatzer PFO Occluder in Patients with Paradoxical Cerebral Embolism "
by: Ali Mohammad Haji Zeinali, et al.
Published: (2006-07-01) -
Interventional Closure of Patent Foramen Ovale (PFO) with Amplatzer PFO Occluder in Patients with Paradoxical Cerebral Embolism
by: Ali Mohammad Haji Zeinali, et al.
Published: (2006-08-01) -
Patent foramen ovale occlusion with the Cocoon PFO Occluder. The PROS-IT collaborative project
by: Luca Testa, et al.
Published: (2023-01-01) -
Is every PFO technically appropriate for transcatheter closure?
by: Anastasios Apostolos, et al.
Published: (2022-09-01) -
Antithrombotic Therapy Following Structural Heart Disease Interventions: Current Status and Future Directions
by: Andreas Mitsis, et al.
Published: (2024-02-01)